Human SCF / KITLG (26-189) Protein, premium grade
分子別名(Synonym)
KITLG,FPH2,KL-1,Kitl,MGF,SCF,SF,SHEP7,KL
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human SCF (26-189), premium grade (SCF-H5219) is expressed from human 293 cells (HEK293). It contains AA Glu 26 - Ala 189 (Accession # P21583-1).
Predicted N-terminus: Glu 26
該產(chǎn)品是在我們嚴(yán)格的質(zhì)量控制體系下生產(chǎn)的,該體系包含一套全面的測(cè)試,包括無(wú)菌和內(nèi)毒素測(cè)試。在早期臨床前階段,產(chǎn)品性能經(jīng)過(guò)仔細(xì)驗(yàn)證和測(cè)試,以確保其與細(xì)胞培養(yǎng)用途或任何其他應(yīng)用的兼容性。當(dāng)準(zhǔn)備過(guò)渡到后期臨床階段時(shí),我們還提供定制的GMP蛋白質(zhì)服務(wù),以滿足您的需求。我們將與您合作,根據(jù)您的要求定制和開(kāi)發(fā)GMP級(jí)產(chǎn)品,該產(chǎn)品也符合細(xì)胞療法細(xì)胞制造中使用的原材料和輔助材料的要求。
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries no "tag".
The protein has a calculated MW of 18.5 kDa. The protein migrates as 30 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 0.01 EU per μg by the LAL method.
宿主蛋白殘留(Host Cell Protein)
<0.5 ng/μg of protein tested by ELISA.
宿主核酸殘留(Host Cell DNA)
<0.02 ng/μg of protein tested by qPCR.
無(wú)菌(Sterility)
Negative
支原體(Mycoplasma)
Negative.
純度(Purity)
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
干細(xì)胞因子也稱為SCF、KITLG、FPH2、KL-1、Kitl、MGF或SHEP7,是一種與c-kit受體(CD117)結(jié)合的細(xì)胞因子。SCF既可以作為跨膜蛋白存在,也可以作為可溶性蛋白存在。這種細(xì)胞因子在造血(血細(xì)胞的形成)、精子發(fā)生和黑色素生成中起著重要作用。該蛋白的可溶性和跨膜形式是通過(guò)同一R轉(zhuǎn)錄物的選擇性剪接形成的??扇苄院涂缒?/span>SCF由成纖維細(xì)胞和內(nèi)皮細(xì)胞產(chǎn)生??扇苄?/span>SCF的分子量為18.5 KDa,形成二聚體。SCF在胚胎發(fā)育過(guò)程中的造血過(guò)程中起著重要作用。造血發(fā)生的部位,如胎兒肝臟和骨髓,都表達(dá)SCF。在發(fā)育過(guò)程中,SCF的存在在黑素細(xì)胞的定位中也起著重要作用,黑素細(xì)胞是產(chǎn)生黑色素和控制色素沉著的細(xì)胞。SCF在骨髓干細(xì)胞生態(tài)位中對(duì)HSC的調(diào)節(jié)中起著重要作用。SCF可以與其他細(xì)胞因子一起用于培養(yǎng)HSC和造血祖細(xì)胞。這些細(xì)胞在體外(體外)的擴(kuò)增將使骨髓移植取得進(jìn)展,在骨髓移植中,造血干細(xì)胞被轉(zhuǎn)移到患者體內(nèi)以重建血液形成。
關(guān)鍵字: SCF;SCF蛋白;SCF重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。